摘要
随着人类寿命的延长,人口老化,痴呆病人随之增加.按老年人患病率4.5%计算,我国已有540万患者.一个阿尔茨默病(Alzheimer disease简称AD).
出处
《江西医药》
CAS
2003年第2期140-143,共4页
Jiangxi Medical Journal
同被引文献27
-
1von Bernhardi R,Eugenin J. AlzheimerJs disease:redox dysregula- tion as a common denominator for diverse pathogenic mechanisms [J]. Antioxidants & Redox Signaling, 2012,16(9) : 974-1031.
-
2Schonrock N,Matamales M,Ittner LM,et al. MicroRNA networks surrounding APP and amyloid-β metabolism-Implications for Alzheimer's disease [J]. Experimental Neurology,2012,235 (2) : 447:454.
-
3Walker KR,Kang EL,Whalen MJ,et al. Depletion of GGA1 and GGA3 mediates postinjury elevation of BAGEl [J]. The Journal of Neuroscience, 2012,32(30) : 10423 - 10437.
-
4Bateman R.I ,Xiong C ,Benzinger TLS ,et al. Clinical and biomarker claanges in dominantly inherited Alzheimer's disease[J]. New Eng- land Journal of Medicine, 2012,367(9) :795-804.
-
5Gao CM,Yam AY,Wang X,et al. Ab40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's [J]. 2010,5 (12) : e15725.
-
6Koopman K, Le Bastard N, Martin JJ, et al. Improved discrimination ofl autopsy-confirmed Alzheimer's disease (AD) from non-AD de- mentias using CSF P-tau 181P [J]. Neumchemistry international, 2009,55(4):214-218.
-
7Buerger K,Ewers M ,Pirttil? T,et al. CSF phosphorylated tau pro- tein correlates with neocortical neurofibrillary pathology in Alzheimer's disease[J]. Brain, 2006,129(11) : 3035-3041.
-
8Mattsson N,Zetterberg H,Hansson O,et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impair- ment[J]. Jama, 2009,302(4) : 385-393.
-
9Thaweepoksomboon J, Senanarong V, Poungvarin N, et al. Assess- ment of eerebrospinal fluid (CSF) beta-amyloid (1-42),phosphory- lated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand [J]. Journal of the Medical Association of Thailand=Chot- maihet thangphaet, 2011,94( 1 ) : $77-83.
-
10Perrin RJ,Craig-Schapiro R, Malone JP,et al. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease[J]. PLoS One, 2011,6(1) : e16032.
二级引证文献11
-
1毛细江,黄丹,王宏伟,王昌权,路承彪,涂强.DR_4的激活在治疗阿尔茨海默病应用中的新研究[J].江西医药,2017,52(3):200-203. 被引量：2
-
2许伟坚.孕早期七氟烷母体麻醉对子代大鼠认知功能的影响及其机制[J].中国临床药理学杂志,2017,33(20):2051-2053. 被引量：2
-
3郑旭光,颜文,张振杰,段立广,张磊,李德强,杨树民.HPLC法测定龙胆健肝胶囊中5种有效成分的含量[J].中国临床药理学杂志,2017,33(20):2073-2076. 被引量：2
-
4贺聿国,薛建军,申治国,耿清胜,张永年.小剂量乌拉地尔复合右美托咪定在老年腹腔镜手术充气期间对七氟醚用量和麻醉深度的影响[J].山西医药杂志,2018,47(3):302-304. 被引量：2
-
5代景伟,段宗伟.七氟烷对老年大鼠认知功能及海马组织中β-淀粉样蛋白表达的影响[J].中国临床药理学杂志,2018,34(18):2183-2186. 被引量：5
-
6易国萍,朱小英.中国人群尿中AD7c-NTP含量与阿尔茨海默病关系的Meta分析[J].江西医药,2018,53(9):971-973. 被引量：3
-
7杨志勇,陈雄辉,陈娜.老年急性脑梗死认知功能障碍的特点及其与血浆pro-BNP和CRP的关系[J].江西医药,2018,53(10):1099-1100. 被引量：5
-
8刘琦,陈雄辉,杨志勇.老年急性脑梗死认知功能障碍的特点及其与血浆pro- BNP和CRP的相关性[J].中国老年学杂志,2019,39(10):2330-2332. 被引量：22
-
9刘楚杰,史峰,吴莉莉.尤瑞克林治疗急性脑梗死合并认知功能障碍患者的疗效及其对炎性因子的影响[J].江西医药,2019,54(7):766-768. 被引量：6
-
10彭伟涛,任玥(综述),吴晓牧(审校).辅酶Q10对阿尔茨海默病治疗作用的研究进展[J].江西医药,2020,55(1):91-94. 被引量：2
-
1朱见文,靳彦华,冯彦敏.血管性痴呆患者血浆同型半胱氨酸监测的意义[J].临床荟萃,2009,24(10):876-877.
-
2刘登会,程燕玲,王维平.尼莫同治疗血管性痴呆临床观察[J].临床荟萃,2001,16(16):746-747.
-
3陈柏铭,刘利东,陈盛强,燕启江.载脂蛋白E基因多态性与阿尔茨默病的关系探讨[J].广州医学院学报,2001,29(1):5-7. 被引量：2
-
4任淑萍.老年性痴呆症治疗药物进展[J].中国医院用药评价与分析,2003,3(5):315-317. 被引量：2
-
5李芝.老年性痴呆患者的家庭护理探讨[J].工企医刊,2008,21(2):39-41.
-
6佘明德.老年性痴呆预防有办法[J].祝您健康,1995,0(10):34-34.
-
7王道珍,于亮.阿尔茨默病认识功能障碍的药物治疗[J].医学综述,1997,3(6):264-265.
-
8傅超明.45例阿尔采末病临床分析[J].健康心理学杂志,2000,8(1):104-105.
-
9杨萍.β淀粉样蛋白与阿尔茨海默病研究[J].医学综述,2001,7(10):604-605. 被引量：4
-
10周龙平,覃远生.老年性痴呆的研究现状[J].中国医学文摘（内科学）,2005,26(5):657-660. 被引量：5
